טוען...
Emerging treatment options for BRAF-mutant colorectal cancer
The personalization of cancer care is rooted in the premise that there are subsets of patients with tumors harboring clinically relevant targets for patient-specific treatments. Colorectal cancer (CRC) is a disease that has historically been notable for its dearth of biomarkers that are predictive o...
שמור ב:
| הוצא לאור ב: | Gastrointest Cancer |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5889076/ https://ncbi.nlm.nih.gov/pubmed/29628780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/GICTT.S125940 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|